222 related articles for article (PubMed ID: 14620520)
21. Dissolution of a Biopharmaceutics Classification System Class II Free Acid from Immediate Release Tablets Containing a Microenvironmental pH Modulator: Comparison of a Biorelevant Bicarbonate Buffering System with Phosphate Buffers.
Haznar-Garbacz D; Hoc D; Garbacz G; Lachman M; Słomińska D; Romański M
AAPS PharmSciTech; 2022 Jul; 23(6):203. PubMed ID: 35882674
[TBL] [Abstract][Full Text] [Related]
22. Dissolution properties of co-amorphous drug-amino acid formulations in buffer and biorelevant media.
Heikkinen AT; DeClerck L; Löbmann K; Grohganz H; Rades T; Laitinen R
Pharmazie; 2015 Jul; 70(7):452-7. PubMed ID: 26373205
[TBL] [Abstract][Full Text] [Related]
23. An automated system for monitoring and regulating the pH of bicarbonate buffers.
Garbacz G; Kołodziej B; Koziolek M; Weitschies W; Klein S
AAPS PharmSciTech; 2013 Jun; 14(2):517-22. PubMed ID: 23468339
[TBL] [Abstract][Full Text] [Related]
24. Mechanistic analysis and experimental verification of bicarbonate-controlled enteric coat dissolution: Potential in vivo implications.
Al-Gousous J; Ruan H; Blechar JA; Sun KX; Salehi N; Langguth P; Job NM; Lipka E; Loebenberg R; Bermejo M; Amidon GE; Amidon GL
Eur J Pharm Biopharm; 2019 Jun; 139():47-58. PubMed ID: 30872012
[TBL] [Abstract][Full Text] [Related]
25. Evolution of a physiological pH 6.8 bicarbonate buffer system: application to the dissolution testing of enteric coated products.
Liu F; Merchant HA; Kulkarni RP; Alkademi M; Basit AW
Eur J Pharm Biopharm; 2011 May; 78(1):151-7. PubMed ID: 21255647
[TBL] [Abstract][Full Text] [Related]
26. Improved Prediction of in Vivo Supersaturation and Precipitation of Poorly Soluble Weakly Basic Drugs Using a Biorelevant Bicarbonate Buffer in a Gastrointestinal Transfer Model.
Jede C; Wagner C; Kubas H; Weigandt M; Weber C; Lecomte M; Badolo L; Koziolek M; Weitschies W
Mol Pharm; 2019 Sep; 16(9):3938-3947. PubMed ID: 31335153
[TBL] [Abstract][Full Text] [Related]
27. Role of bicarbonate/CO2 buffer in the initiation of vesicle-mediated calcification: mechanisms of aortic calcification related to atherosclerosis.
Hsu HH; Abbo BG
Biochim Biophys Acta; 2004 Oct; 1690(2):118-23. PubMed ID: 15469900
[TBL] [Abstract][Full Text] [Related]
28. Reaction plane approach for estimating the effects of buffers on the dissolution rate of acidic drugs.
McNamara DP; Amidon GL
J Pharm Sci; 1988 Jun; 77(6):511-7. PubMed ID: 3171931
[TBL] [Abstract][Full Text] [Related]
29. Dissolution of ionizable drugs in buffered and unbuffered solutions.
Ozturk SS; Palsson BO; Dressman JB
Pharm Res; 1988 May; 5(5):272-82. PubMed ID: 3244637
[TBL] [Abstract][Full Text] [Related]
30. Toward Biopredictive Dissolution for Enteric Coated Dosage Forms.
Al-Gousous J; Amidon GL; Langguth P
Mol Pharm; 2016 Jun; 13(6):1927-36. PubMed ID: 27139040
[TBL] [Abstract][Full Text] [Related]
31. The impact of reduced gastric acid secretion on dissolution of salts of weak bases in the fasted upper gastrointestinal lumen: Data in biorelevant media and in human aspirates.
Litou C; Vertzoni M; Xu W; Kesisoglou F; Reppas C
Eur J Pharm Biopharm; 2017 Jun; 115():94-101. PubMed ID: 28214603
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the physicochemical properties and dissolution characteristics of mesalamine: relevance to controlled intestinal drug delivery.
French DL; Mauger JW
Pharm Res; 1993 Sep; 10(9):1285-90. PubMed ID: 8234164
[TBL] [Abstract][Full Text] [Related]
33. The effect of selected water-soluble excipients on the dissolution of paracetamol and Ibuprofen.
Shaw LR; Irwin WJ; Grattan TJ; Conway BR
Drug Dev Ind Pharm; 2005 Jul; 31(6):515-25. PubMed ID: 16109624
[TBL] [Abstract][Full Text] [Related]
34. Predicting the gastrointestinal behaviour of modified-release products: utility of a novel dynamic dissolution test apparatus involving the use of bicarbonate buffers.
Merchant HA; Goyanes A; Parashar N; Basit AW
Int J Pharm; 2014 Nov; 475(1-2):585-91. PubMed ID: 25195730
[TBL] [Abstract][Full Text] [Related]
35. Selection of In Vivo Predictive Dissolution Media Using Drug Substance and Physiological Properties.
Mudie DM; Samiei N; Marshall DJ; Amidon GE; Bergström CAS
AAPS J; 2020 Jan; 22(2):34. PubMed ID: 31989343
[TBL] [Abstract][Full Text] [Related]
36. Mechanistic understanding of underperforming enteric coated products: Opportunities to add clinical relevance to the dissolution test.
Amaral Silva D; Davies NM; Doschak MR; Al-Gousous J; Bou-Chacra N; Löbenberg R
J Control Release; 2020 Sep; 325():323-334. PubMed ID: 32649973
[TBL] [Abstract][Full Text] [Related]
37. Matching phosphate and maleate buffer systems for dissolution of weak acids: Equivalence in terms of buffer capacity of bulk solution or surface pH?
Cristofoletti R; Dressman JB
Eur J Pharm Biopharm; 2016 Jun; 103():104-108. PubMed ID: 27032508
[TBL] [Abstract][Full Text] [Related]
38. In vitro prediction of in vivo absorption of ibuprofen from suspensions through rational choice of dissolution conditions.
Hofmann M; García MA; Al-Gousous J; Ruiz-Picazo A; Thieringer F; Nguyen MA; Månsson W; Galle PR; Langguth P
Eur J Pharm Biopharm; 2020 Apr; 149():229-237. PubMed ID: 32112894
[TBL] [Abstract][Full Text] [Related]
39. pH-dependent dissolution in vitro and absorption in vivo of weakly basic drugs: development of a canine model.
Zhou R; Moench P; Heran C; Lu X; Mathias N; Faria TN; Wall DA; Hussain MA; Smith RL; Sun D
Pharm Res; 2005 Feb; 22(2):188-92. PubMed ID: 15783065
[TBL] [Abstract][Full Text] [Related]
40. In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib.
Tsume Y; Takeuchi S; Matsui K; Amidon GE; Amidon GL
Eur J Pharm Sci; 2015 Aug; 76():203-12. PubMed ID: 25978875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
